Continuing Education
The Drug Information Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
This program is designated for up to 21 contact hours or 2.1 continuing education units (CEU’s).
ACPE Credit Requests MUST BE SUBMITTED by Wednesday, March 12, 2025. DIA is required by the Accreditation Council for Pharmacy Education (ACPE) to report pharmacy-requested CEUs through the CPE Monitor system. All ACPE-certified activity credit requests need to be submitted through DIA's My Transcript within 45-days post activity. If ACPE credit is not requested by Wednesday, March 12, 2025, the CEU request will not be transmitted through to the CPE Monitor. Pharmacists will need to provide their National Association of Boards of Pharmacy (NABP) e-Profile ID and date of birth (MMDD) to ensure the data is submitted to the ACPE and NABP properly. If you need to obtain your NABP e-Profile, please visit www.cpemonitor.net.
CE ALLOCATION:
- January 26, 2025 – Aggregate Safety Assessment Planning (ASAP) Process - In Person: ACPE: 5.5 contact hours or .55 CEUs, Type of Activity: Knowledge, 0286-0000-25-003-L04-P
- January 26, 2025 – Introduction to Statistics in Drug Safety - In Person: ACPE: 2.75 contact hours or .275 CEUs, Type of Activity: Knowledge, 0286-0000-25-004-L04-P
- January 27, 2025 - Global Pharmacovigilance and Risk Management Strategies Conference – Day 1: ACPE: 5.75 contact hours or .575 CEUs, Type of Activity: Knowledge, 0286-0000-25-005-L04-P
- January 28, 2025 - Global Pharmacovigilance and Risk Management Strategies Conference – Day 2: ACPE: 5.75 contact hours or .575 CEUs, Type of Activity: Knowledge, 0286-0000-25-006-L04-P
- January 29, 2025 - Global Pharmacovigilance and Risk Management Strategies Conference – Day 3: ACPE: 4 contact hours or .4 CEUs, Type of Activity: Knowledge, 0286-0000-25-007-L04-P
DIA Disclosure Policy
It is DIA policy that anyone in a position to control the content of a continuing education activity must disclose to the program audience (1) any relevant financial relationships related to the content of their presentation and/or the educational activity, and (2) discussions of unlabeled or unapproved uses of drugs or medical devices. Disclosures will be included in the handout materials.
This educational activity may include references to the use of products for indications not approved by the FDA. Opinions expressed with regard to unapproved uses of products are solely those of the faculty and are not endorsed by the DIA or any of the manufacturers of products mentioned herein. Faculty for this educational activity was asked to disclose any discussion of unlabeled or unapproved uses of drugs or medical devices.
Disclosure statements are included with each speaker’s biographical sketch.
| Name | Credit Type | Max Credits | CEU |
| Global Pharmacovigilance and Risk Management Strategies Conference | Credit TypeACPE | Max Credits15.50 | CEU1.550 |
| Short Course: Aggregate Safety Assessment Planning (ASAP) Process | Credit TypeACPE | Max Credits5.50 | CEU0.550 |
| Short Course: Introduction to Statistics in Drug Safety | Credit TypeACPE | Max Credits2.75 | CEU0.275 |
Statement of Credit:
If you are claiming CE credit for the conference you must:
- Attend one, two, or all three days of the conference, (in their entirety)
- Sign in at the DIA registration desk each day, upon arrival
- Access your DIA account and select My Transcript to claim your ACPE credit, available on Wednesday, February 12, 2025.
- ACPE credit must be submitted by Wednesday, March 12, 2025.
- Visit DIAglobal.org, select “Sign in” and you will be prompted for your user ID and password
- Under EVENTS select “Continuing Education"
- Select My Account from the menu
- Select the blue “My Transcript” button followed by “Credit Request” to process your credit request for the course
To access My Transcript: